Advancing Glioblastoma Therapy: Promising Research in Precision Medicine

Q2 Pharmacology, Toxicology and Pharmaceutics Drug Delivery Letters Pub Date : 2023-08-18 DOI:10.2174/2210303113666230818113653
Nisha V Kalayil, P. Paul, Showkhiya Y. Khan, Shona S. D'Souza
{"title":"Advancing Glioblastoma Therapy: Promising Research in Precision Medicine","authors":"Nisha V Kalayil, P. Paul, Showkhiya Y. Khan, Shona S. D'Souza","doi":"10.2174/2210303113666230818113653","DOIUrl":null,"url":null,"abstract":"\n\nThe goal of precision medicine is to create treatments for a single person or group of people based on information about their physical condition in the present and the past as well as their exposure to the environment. Precision medicine is now having an impact on how people are treated for their health at different periods of their lives through a variety of applications. Applications of precision medicine can help prevent death, alert patients regarding genetic risks, lower medical expenses, and enhance the quality of life. To determine the risk that a child may inherit an illness, genetic testing is performed before conception. The most severe type of brain cancer is glioblastoma (GBM), commonly referred to as grade IV astrocytoma. Although they can penetrate the brain, GBMs normally do not spread to other organs. One effective kind of treatment for glioblastoma is precision medicine, which is currently being developed. Numerous improvements in diagnosis and therapy have resulted in the healing of many patients without having an impact on their way of life. In terms of diagnosis and treatment, this article compares and contrasts precision technology and traditional therapy. Stem cell treatment, immunotherapy, and combination therapy are all extensively described.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303113666230818113653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The goal of precision medicine is to create treatments for a single person or group of people based on information about their physical condition in the present and the past as well as their exposure to the environment. Precision medicine is now having an impact on how people are treated for their health at different periods of their lives through a variety of applications. Applications of precision medicine can help prevent death, alert patients regarding genetic risks, lower medical expenses, and enhance the quality of life. To determine the risk that a child may inherit an illness, genetic testing is performed before conception. The most severe type of brain cancer is glioblastoma (GBM), commonly referred to as grade IV astrocytoma. Although they can penetrate the brain, GBMs normally do not spread to other organs. One effective kind of treatment for glioblastoma is precision medicine, which is currently being developed. Numerous improvements in diagnosis and therapy have resulted in the healing of many patients without having an impact on their way of life. In terms of diagnosis and treatment, this article compares and contrasts precision technology and traditional therapy. Stem cell treatment, immunotherapy, and combination therapy are all extensively described.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
推进胶质母细胞瘤治疗:精准医学的前景研究
精准医疗的目标是根据一个人或一群人现在和过去的身体状况以及他们所处环境的信息,为他们创造治疗方法。精准医疗现在正通过各种应用影响着人们在生命的不同阶段如何治疗他们的健康。精准医疗的应用可以帮助预防死亡,提醒患者注意遗传风险,降低医疗费用,提高生活质量。为了确定孩子可能遗传某种疾病的风险,在怀孕前进行基因检测。最严重的脑癌类型是胶质母细胞瘤(GBM),通常被称为IV级星形细胞瘤。虽然它们可以穿透大脑,但GBMs通常不会扩散到其他器官。一种有效的治疗胶质母细胞瘤的方法是目前正在开发的精准医学。在诊断和治疗方面的许多改进使许多患者在不影响其生活方式的情况下痊愈。在诊断和治疗方面,本文对精密技术和传统疗法进行了比较和对比。干细胞治疗、免疫治疗和联合治疗都被广泛地描述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Delivery Letters
Drug Delivery Letters Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
1.70
自引率
0.00%
发文量
30
期刊最新文献
In-vitro and In-silico Examinations on Baicalein-loaded Solid Lipid Nanoparticles for Neurodegeneration D-Optimal Mixture Design Enabled Development of Lyophilized Nanoemulsifying Drug Delivery System of Paliperidone Intranasal Route an Alternative Approach for Systemic Drug Delivery: Recent Strategies and Progression Revolutionizing Nitrofurantoin Delivery: Unraveling Challenges and Pioneering Solutions for Enhanced Efficacy in UTI Treatment Hot Melt Extrusion Technique for Developing Pharmaceutical Co-crystals: A Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1